Latest news with #PrathapCReddy
Business Standard
2 hours ago
- Business
- Business Standard
Apollo Hospital rallies after board OKs demerger of digital & pharmacy units
Apollo Hospital Enterprise (AHEL) added 3.25% to Rs 7,477.95 after the company's board approved to spin-off its omnichannel pharmacy and digital health businesses through scheme of arrangement. The board of AHEL and its subsidiary, Apollo HealthCo granted in-principle approval for the demerger of Omnichannel Pharma and Digital Health business. The proposed structure enables direct access of omni-channel pharmacy and digital health business to the shareholders of AHEL. For every 100 shares of AHEL, the shareholders of AHEL will receive 195.2 shares of the new company, Apollo Healthtech enabling their direct participation in the value unlock. The proposed transaction will result in the creation of the largest, integrated omni channel healthcare eco-system with a FY25 revenue of approximately Rs 16,300 crore ($ 1.9 billion) in FY25. The Apollo Healthtech is expected to achieve a revenue run rate of Rs 25,000 crore ($2.9 billion) by FY27. Upon the effectiveness of the Scheme, Apollo Healthtech will become an Indian owned and controlled company (IOCC) and it will apply for listing on the stock exchanges. The listing is expected within 18 to 21 months. AHEL will retain 15% stake in the Apollo Healthtech to ensure an integrated, seamless, and comprehensive healthcare offering across the patient lifecycle. Upon becoming an IOCC, the Apollo Healthtech also proposes to consolidate the front-end pharmacy business by acquiring the remaining 74.5% stake in Apollo Medicals (AMPL), which owns 100% of APL. Dr Prathap C Reddy, chairman, Apollo Hospitals Group, said "Today's developments mark the beginning of the next chapter of Apollo Hospitals' relentless mission to bring healthcare of world-class standards within the reach of every individual. The omnichannel pharmacy business and integrated digital healthcare ecosystem will be a unique model to enable access to high-quality healthcare for millions of Indians. What Apollo Hospitals achieved for the creation of the private healthcare industry in India, this new entity will create for the digitally forward generation of tomorrow. We have the opportunity to make a positive difference to their lives and partner in their wellness pursuits. I wish both the teams all the best as they enter uncharted territory with infinite potential." Suneeta Reddy, managing director, Apollo Hospitals Enterprise said, "Apollo has always focused on growth, reach, and scale. We have carefully built our formats-of-care around the consumer at the centre. This comprehensive integrated network, overlaid with a strong digital layer, will allow us to create an impact of magnitude greater than could be achieved with a single format of care. AHEL will continue its focus on outstanding healthcare delivery, while the New Entity will accelerate its efforts on deepening customer engagement and penetration, with clear capital allocation outlays, growth plans and management teams driving both. Together, we will generate unparalleled value for the consumer, while making sure that all synergies and network effects stay intact, rooted in the Apollo ethos of quality and trust." Shobana Kamineni, executive chairperson, Apollo HealthCo said, "The New Entity, once integrated, will be a truly customer-focused healthcare leader, with capabilities across the value chain. Delivering medicines seamlessly from more than 7,000 physical stores, online delivery platform serving over 19,000 pincodes, with Keimed ensuring supply chain integrity, our aspiration is that we will serve over 100 million Indians with trusted quality and availability. With each business expected to record healthy rates of growth, we will continue to be the leader in this sector. Apollo Hospitals Enterprise has established a strong presence across the healthcare ecosystem, encompassing hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models. The company reported 53.5% jump in consolidated net profit to Rs 389.60 crore on 13.1% increase in revenue from operations to Rs 5,592.20 crore in Q4 FY25 over Q4 FY24.
Time of India
18 hours ago
- Business
- Time of India
Apollo Hospitals to hive off pharmacy, digital biz
Chennai: Apollo Hospitals Enterprise, controlled by the Prathap Reddy family, has announced a significant reorganisation where its pharmacy distribution and digital health operations will be carved out into a separate entity. This new entity, Apollo Healthtech, will seek listing on stock exchanges over the next 18 to 21 months, with current Apollo Hospitals shareholders receiving proportionate shares in the new company. The deal will create a leading omni-channel pharmacy distribution and digital health platform in India with revenues of Rs 16,300 crore ($1.9 billion), Apollo Hospitals said in a statement. Currently, Apollo Healthco (AHL) manages the wholesale pharmaceutical trading and Apollo 24/7 digital platform, while Keimed oversees wholesale distribution of pharmaceuticals and wellness products. Apollo Hospitals holds about 79% ownership in AHL, and Keimed operates as a related party to Apollo Hospitals. You Can Also Check: Chennai AQI | Weather in Chennai | Bank Holidays in Chennai | Public Holidays in Chennai The share allocation structure stipulates that for every 100 shares held in Apollo Hospitals, shareholders will receive 195.2 shares in the new company. AHL shareholders will get 89.5 shares for every 100 shares owned, while Keimed shareholders will receive 3045.2 shares for every 100 shares held. Following the completion of this demerger, both AHL and Keimed will cease to exist. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cardiologists: 1 Teaspoon of This Before Bed Melts Belly Fat Like Crazy Hollywood News | USA Click Here Undo Under the agreement terms, Apollo Hospitals shall restrict its pharmaceutical operations exclusively to hospital-based pharmacies, refraining from any involvement in e-commerce, retail or wholesale pharmacy ventures. Veda Corporate Advisors was the exclusive financial advisor to the transaction. The new company, Apollo Healthtech, will subsequently acquire 74.5% stake in Apollo Medicals, consolidating the front-end pharmacy business. Apollo Hospitals will own a 15% stake in Apollo Healthtech and will have one nominee director on the board, the Chennai-based company said. Apollo Hospitals chairman Prathap C Reddy, said: "Today's developments mark the beginning of the next chapter of Apollo Hospitals. The omnichannel pharmacy business and integrated digital healthcare ecosystem will be a unique model to enable access to high-quality healthcare for millions of Indians."
Time of India
21 hours ago
- Business
- Time of India
Apollo Hospitals to hive-off pharmacy, digital health businesses
Apollo Hospitals Enterprise on Monday said its board has approved separate listing of its omnichannel pharmacy and digital health businesses within 18-21 months, as part of reorganisation exercise to unlock value. The board of directors of Apollo Hospitals and Apollo HealthCo, a subsidiary of the the healthcare major, have accorded in-principle approval for the composite scheme of arrangement. The scheme entails the demerger of the Omni Channel Pharma and Digital Health business -- comprising the telehealth business of Apollo and its investment in AHL (Apollo HealthCo Limited) -- into a new entity. Following the demerger, the scheme provides for the amalgamation of AHL with the new entity. It would subsequently be followed by the amalgamation of Keimed Pvt Ltd , India's leading wholesale pharmaceutical distributor, with NewCo (new entity). Live Events The scheme creates a formidable omnichannel pharmacy distribution and digital health platform leader in India, with stated plans to achieve Rs 25,000 crore revenue by FY27, Apollo Hospitals Enterprise said in a regulatory filing. Upon the effectiveness of the Scheme, the new entity will become an Indian Owned and Controlled Company (IOCC) and will apply for listing on the stock exchanges, it added. The listing is expected within 18-21 months, the healthcare major said. Upon becoming an IOCC, the entity also proposes to consolidate the front-end pharmacy business by acquiring the remaining 74.5 per cent stake in Apollo Medicals Pvt Ltd (AMPL), which owns 100 per cent of Apollo Pharmacies Limited (APL), it said. Apollo Hospitals Enterprise Ltd (AHEL) will retain 15 per cent stake in the 'NewCo' to ensure an integrated, seamless, and comprehensive healthcare offering across the patient lifecycle, it added. "The omnichannel pharmacy business and integrated digital healthcare ecosystem will be a unique model to enable access to high-quality healthcare for millions of Indians," Apollo Hospitals Group Chairman Prathap C Reddy said. Apollo Hospitals Enterprise MD Suneeta Reddy said the proposal enables the healthcare provider's shareholders to gain direct shareholding to country's largest omni-channel pharmacy and digital health platform. "The new entity, once integrated, will be a truly customer-focused healthcare leader, with capabilities across the value chain. Delivering medicines seamlessly from 7000+ physical stores, online delivery platform serving over 19,000 pincodes, with Keimed ensuring supply chain integrity, our aspiration is that we will serve over 100 million Indians," Apollo HealthCo Executive Chairperson Shobana Kamineni said. Shares of Apollo Hospitals Enterprise ended 0.87 per cent down at Rs 7,242.75 apiece on BSE. Economic Times WhatsApp channel )
Business Standard
02-06-2025
- Business
- Business Standard
Apollo Hospitals gains after Q4 PAT jumps 53% YoY to Rs 390 cr
Apollo Hospitals Enterprise added 1.70% to Rs 6,994.95 after the company reported 53.5% jump in consolidated net profit to Rs 389.60 crore on 13.1% increase in revenue from operations to Rs 5,592.20 crore in Q4 FY25 over Q4 FY24. Profit before tax (PBT) jumped 40% YoY to Rs 515.50 crore in the quarter ended 31st March 2025. EBITDA grew 20% to Rs 769.9 crore in Q4 FY25 as compared with Rs 640.5 crore in Q4 FY24. EBITDA margin stood at 13.8% in Q4 FY25 as against 13% in Q4 FY24. Revenue from healthcare services increased 10% YoY to Rs 2,822 crore, revenue from Apollo health and lifestyle (AHLL) stood at Rs 394 crore, up 11% YoY and revenue from Apollo healthCo was at Rs 2,376.3 crore, up 17% YoY. As on March 31, 2025, Apollo Hospitals had 8,025 operating beds across the network (excluding AHLL & managed beds). The overall occupancy for hospitals was at 67% as against 65% in the same period in the previous year. On full year basis, the companys consolidated net profit climbed 60.9% to Rs 1,445.90 crore on 14.3% increase in revenue from operations to Rs 21,794 crore in FY25 over FY24. Dr. Prathap C Reddy, chairman, Apollo Hospitals Enterprise, said: At Apollo, our mission has always gone beyond treating illness-it is about enabling every individual to live a healthier, happier life. FY25 was a defining year. With revenues crossing approximately Rs 20,000 crore and Healthcare Services surpassing around Rs 11,000 crore, we are humbled by the trust placed in us across India and beyond. To address the rising burden of non-communicable diseases, we are intensifying our preventive care mission. Through Apollo ProHealth, we are set to globally launch pioneering wellness programs that redefine the healthcare landscape - shifting the focus from reactive treatment to proactive, preventive care. We are committed to growth and to the enhancement of our care toucbpoints, with new hospitals to be commissioned this year in Pune, Kolkata, Hyderabad, Bangalore and Delhi NCR - and several more in varying stages of development. These state-of-the-art facilities will be equipped with cutting-edge medical technology, reinforcing our commitment to delivering world-class care at scale. Our over Rs 8,000 crore investment over the next five years will add over 4,300 beds, with the first phase of - 2,000 beds already in progress-bringing advanced care closer to communities across India. Apollo Pharmacies crossed 6,600 stores this year and Apollo 24/7 commenced distribution of Insurance products to increase access to care. Meanwhile, the companys board recommended a final dividend of Rs 10 per equity share with a face value of Rs 5 each for FY25. The board has fixed the record date as Tuesday, 19th August 2025. The dividend, if declared at the annual general meeting will be paid on or before 10th September 2025. Further, the companys board has approved a proposal to purchase a land parcel admeasuring 2.53 acres at Sarjapur, Bengaluru for setting up a 500-bed greenfield multi-specialty hospital, at an estimated overall cost of Rs 944 crore. Additionally, the company will also be acquiring a 200 bedded hospital located in the vicinity of the land parcel identified for setting up the 500 bed greenfield hospital. The overall cost of acquiring the existing hospital facility (expandable to 200 beds immediately) and upgrading the existing hospital infrastructure is estimated to be Rs 285 crore. Apollo Hospitals Enterprise has established a strong presence across the healthcare ecosystem, encompassing hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models. The Group also offers telemedicine services in multiple countries, health insurance solutions, global project consultancy, and operates medical colleges, a nursing and hospital management college, and Medvarsity for e-learning. Additionally, it is supported by a dedicated research foundation.
Time of India
01-05-2025
- Health
- Time of India
Apollo Diagnostics launches Automated Laboratory Facility in Chennai
Chennai: Healthcare service provider Apollo Diagnostics has launched its Digi-Smart Central Reference Laboratory (CRL), in Chennai. The company claims to deliver a 60% reduction in Laboratory sample Turnaround Time (TAT) through this initiative. The facility combines five laboratory disciplines—clinical chemistry, immunoassay, serology, hematology, and hemostasis—into a single, digitally monitored and automated system, using robotics, imaging tools, bespoke algorithms, and machine learning to manage operations. According to the company, the CRL provides a menu of more than 3,000 tests and includes capabilities in microbiology, serology, flow cytometry, histopathology, cytopathology, immunohistochemistry, molecular biology, and medical genetics test. Commenting on the development, Dr. Prathap C Reddy, Founder and Chairman, Apollo Hospitals said, "By seamlessly combining five key laboratory disciplines with advanced automation, this lab delivers faster, more accurate results, directly translating to better patient outcomes.'
